FDANonrulemakingFDA-2017-N-2936
Who commented on this docket
Content of Risk Information in the Major Statement in Prescription Drug Direct-to-Consumer Broadcast Advertisements; Request for Information and Comments
7 organizations filed 7 public comments on Content of Risk Information in the Major Statement in Prescription Drug Direct-to-Consumer Broadcast Advertisements; Request for Information and Comments, at the Food and Drug Administration. The comment window closed 3172d ago.
Organizations
7
Comments
7
RIN
—
Comment window
closed 3172d ago
Commenters (7)
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- Coalition for Healthcare Communicationtrade assoc.1 filing · confidence 85%
- Eli Lilly and Companyunverified attribution1 filing · confidence 70%
- Gilead Sciences Inc.unverified attribution1 filing · confidence 70%
- National Association of Broadcasterstrade assoc.1 filing · confidence 85%
- Pharmaceutical Care Management Associationtrade assoc.1 filing · confidence 85%
- The Association of Magazine Mediatrade assoc.1 filing · confidence 85%
Attribution is name-based and imperfect. regulations.gov data is public record.